Preclinical study: after heart attack, a boost in anti-inflammatory cells promoted healing
A scientific technique that rapidly increases the body's production of anti-inflammatory cells promoted healing from heart attacks in mice, according...
adminph
Genome editing offers hope for genetic hearing loss
New therapy developed to repair GJB2 R75W mutation Scientists from Juntendo University and The University of Tokyo have created an...
Amivantamab plus lazertinib shows survival benefit in lung cancer
Janssen drug combination extends life expectancy during trial Janssen-Cilag International NV has announced results from the phase 3 MARIPOSA study,...
Bayer and Puhe BioPharma enter into global license agreement for clinical phase I PRMT5 inhibitor
Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, announced that they have entered into a global license...
Linda Härmark
Drug Safety Research Unit appoints Linda Härmark as its Director The Drug Safety Research Unit has announced Linda Härmark as its new Director. She succeeds...
Nouscom reveals promising results for lynch syndrome immunotherapy
NOUS-209 shows potential to intercept cancer in its early stages Nouscom has announced full safety and immunogenicity results from its...
Enzyme engineering opens door to novel therapies for Parkinson's, cancers and other hard-to-target protein diseases
Scientists have long struggled to target proteins that lack defined structure and are involved in cancer, neurodegenerative disorders like Parkinson's...
Seth Benson
Nuclera has appointed Seth Benson as Chief Financial Officer Nuclera, the biotechnology company accelerating protein expression and optimisation through its benchtop eProtein...
Kieron Hall
Sygnature Discovery has appointed Kieron Hall as Chief Commercial Officer Sygnature Discovery has announced the appointment of Kieron Hall as its new Chief Commercial Officer (CCO)...
New tool to boost cancer immunotherapy effects
Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the immune system) have the...
WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants The World Health Organization (WHO) has announced that it has...
Elizabeth Holt
iOnctura has appointed Elizabeth Holt as Chief Business Officer iOnctura has announced the appointment of Elizabeth Holt, former Co-Founder of...
AstraZeneca enters license agreement with Alteogen
AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme™ platform technology....
UK expands mandatory infectious disease reporting requirements
The update is aimed at strengthening local and national surveillance The UK Health Security Agency (UKHSA) has announced that it...
Manjunath Ramarao
Aragen has appointed Manjunath Ramarao as Chief Scientific Officer Aragen has announced the appointment of Manjunath Ramarao as Chief Scientific...
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it has entered into an exclusive collaboration and licensing agreement with Zealand...
Orca Bio’s T-cell therapy shows promise in haematological malignancies
The company is preparing to submit the results to the FDA this year Orca Bio has shared promising results from...
Jonas Bolander
Elekta has appointed Jonas Bolander as Acting President and CEO Elekta has announcement the appointment of Jonas Bolander as Acting...
Keeping fit and building muscle could increase survival rates in cancer patients
Physical fitness and increasing muscle strength could reduce the mortality rate for cancer patients by between 31% to 46%, new...
UKHSA announces new effort to tackle hepatitis C
The agency has launched a whole genome sequencing service to monitor the virus The UK Health Security Agency (UKHSA) has...
